Stocktoria

BiomX Inc. PHGE

NYSE · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-12-18

BiomX Inc. statistics & valuation

Market cap$4.2M

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
201820192019202020212022202320242025
Operating margin (%)
201820192019202020212022202320242025
Return on equity (%)
-29.70% 0.90% -24.30% -52.40% -76.20% -134.60% -849.40% -73.40% 201820192019202020212022202320242025
Shares outstanding
2.3M 2.2M 22.9M 23.3M 29.7M 30.0M 5.1M 1.0M 1.6M 201820192019202020212022202320242025
Net debt ($)
-$47.1M -$16.3M -$3.7M 201820192019202020212022202320242025
Share buybacks ($)
201820192019202020212022202320242025
Return on assets (%)
-28.10% 0.50% -22.30% -42.80% -46.40% -62.20% -104.60% -41.00% -626.00% 201820192019202020212022202320242025
Free cash flow margin (%)
201820192019202020212022202320242025
Debt / equity (×)
0.32× 0.71× 3.63× 201820192019202020212022202320242025
EPS ($)
$1.39 $0.95 $5.10 $58.31 $22.19 201820192019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2019FY2018
Return on assets-626.0%-41.0%-104.6%-62.2%-46.4%-42.8%-22.3%0.5%-28.1%
Return on equity2780.3%-73.4%-849.4%-134.6%-76.2%-52.4%-24.3%0.9%-29.7%
Debt / equity——3.63×0.71×0.32×————
Current ratio0.872.481.584.656.038.4713.581.9824.34

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.